Wadsworth Center

Despite the astronomical costs, it may prove challenging to reverse course and discontinue Zika testing according to a commentary article accompanying a NEJM study.

The assay was developed in the Wadsworth Center Biodefense Laboratory and includes a novel sample prep enabling detection from stool.

The University at Albany this week announced that scientists from its RNA Institute have begun collaborating with researchers from the Wadsworth Center of the New York State Department of Health and Rensselaer Polytechnic Institute to advance new biomedical technologies.

Akonni Biosystems and Albany, NY-based Wadsworth Center are working together under a $300,000 National Institutes of Health grant to develop a closed amplicon PCR microarray to detect encephalitis- and meningitis-causing viruses in cerebral spinal fluid, Akonni said this week.

Agilent Technologies, Columbia University, and others are collaborating on development of the system, which will be based on MassTag PCR.

US News & World Report writes that genetic testing of lung tumors can help identify treatments for patients.

A team of researchers plans to sample Loch Ness for environmental DNA, according to Newsweek.

The New York Times writes about the appearance of mosaicism in healthy people.

In PNAS this week: insecticide resistance patterns Anopheles gambiae mosquito, transcriptome patterns in Pseudomonas aeruginosa during infection, and more.